<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="69822">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02196818</url>
  </required_header>
  <id_info>
    <org_study_id>P01.014.08/00</org_study_id>
    <nct_id>NCT02196818</nct_id>
  </id_info>
  <brief_title>A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup</brief_title>
  <official_title>A Multi-centre, Prospective Post Marketing Surveillance Study to Assess Mid-term Performance of the Mpact Cup in Subjects Requiring Primary Total Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medacta International SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medacta International SA</source>
  <brief_summary>
    <textblock>
      This is a multi-centre, prospective post marketing surveillance study to assess mid-term
      performance of the Mpact cup in subjects requiring primary total hip arthroplasty.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Kaplan-Meier analysis as a measure of implant performance.</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Harris Hip Score.</measure>
    <time_frame>pre-op, 3/6 months, 1,2 and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological analysis as a meausure of safety.</measure>
    <time_frame>3/6 months, 1,2 and 5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Arthritis</condition>
  <condition>Avascular Necrosis</condition>
  <condition>Fracture of the Femoral Neck or Head</condition>
  <condition>Congenital Hip Dysplasia</condition>
  <arm_group>
    <arm_group_label>Mpact Acetabular Shell</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Monitor the performance of the Mpact cup in the treatment of patients with hip joint disease requiring a total hip replacement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mpact Acetabular Shell</intervention_name>
    <description>Total Hip Replacement</description>
    <arm_group_label>Mpact Acetabular Shell</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are willing and able to provide written informed consent for
             participation in the study. Written informed consent must be obtained prior to the
             patient's surgery.

          -  Those presenting with disease that meets the indications for use for Medacta USA
             implants defined by this study (on-label use).

          -  Patients must be willing to comply with the pre and post-operative evaluation
             schedule.

        Exclusion Criteria:

          -  Those with one or more medical conditions identified as a contraindication defined by
             the labeling on any Medacta implants used in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mara Colombo</last_name>
    <phone>0041 91 6966060</phone>
    <email>colombo@medacta.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vail Orthopedics, P.C.</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derek Johnson, MD</last_name>
      <phone>303-214-4500</phone>
      <email>derek@webproze.com</email>
    </contact>
    <investigator>
      <last_name>Derek Johnson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Alphonsus Regional Medical Center</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dennis McGee, MD</last_name>
      <email>dennmcge@sarmc.org</email>
    </contact>
    <investigator>
      <last_name>Dennis McGee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Illinois Bone &amp; Joint Institute, LLC</name>
      <address>
        <city>Libertyville</city>
        <state>Illinois</state>
        <zip>60048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Thadani, MD</last_name>
      <phone>847-247-4000</phone>
      <email>pjtmd1@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Keri Malcom</last_name>
      <phone>847.247.4000</phone>
      <email>kmalcolm@ibji.com</email>
    </contact_backup>
    <investigator>
      <last_name>Peter Thadani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Keri Malcom</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 7, 2016</lastchanged_date>
  <firstreceived_date>July 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Hip Dislocation</mesh_term>
    <mesh_term>Hip Dislocation, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
